ASX - By Stock
|
PCL |
Re:
General Thoughts
|
|
Pulpfiction
|
5.3K |
2.5M |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
5.3K
|
2.5M
|
2
|
|
ASX - By Stock
|
PCL |
Re:
General Thoughts
|
|
Pulpfiction
|
5.3K |
2.5M |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
5.3K
|
2.5M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
390 |
136K |
15 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
136K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
Pulpfiction
|
282 |
106K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
282
|
106K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Pulpfiction
|
80 |
25K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Pulpfiction
|
80 |
25K |
11 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
11
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Application for quotation of securities - ILA
|
|
Pulpfiction
|
45 |
8.7K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
8.7K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
3.7M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
10K
|
3.7M
|
3
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Application for quotation of securities - ILA
|
|
Pulpfiction
|
2 |
585 |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
2
|
585
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
3.7M |
12 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
10K
|
3.7M
|
12
|
|
ASX - By Stock
|
ILA |
Re:
Ann: New data leads to proposed ISLA-101 Phase 2 efficiencies
|
|
Pulpfiction
|
7 |
1.4K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
7
|
1.4K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
3.7M |
15 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
10K
|
3.7M
|
15
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Entitlement Offer Document
|
|
Pulpfiction
|
7 |
3.7K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
7
|
3.7K
|
0
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
24 |
9.8K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
24
|
9.8K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
Pulpfiction
|
27 |
9.2K |
5 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
27
|
9.2K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
Pulpfiction
|
27 |
9.2K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
27
|
9.2K
|
7
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
Pulpfiction
|
12K |
3.2M |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
12K
|
3.2M
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
15 |
4.7K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
15
|
4.7K
|
0
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Positive data from ISLA-101 Single Ascending Dose study
|
|
Pulpfiction
|
16 |
5.1K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
16
|
5.1K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX100 Ph1b results to be presented at specialist congress
|
|
Pulpfiction
|
15 |
10K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
15
|
10K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Expands Specialist AP Team - First Female for MDMA-AT
|
|
Pulpfiction
|
5 |
1.6K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
5
|
1.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
Pulpfiction
|
6 |
2.2K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
6
|
2.2K
|
2
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Results of Rights Issue Offer
|
|
Pulpfiction
|
22 |
5.6K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
22
|
5.6K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
530 |
257K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
530
|
257K
|
0
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Earaheedy Project Tenement Acquisition Completed
|
|
Pulpfiction
|
4 |
2.7K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4
|
2.7K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix to Present at Euroz Hartleys Conference
|
|
Pulpfiction
|
112 |
31K |
10 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
112
|
31K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
Pulpfiction
|
89 |
36K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
89
|
36K
|
2
|
|
ASX - By Stock
|
ILA |
Re:
Ann: $1.95million Fully Underwritten Rights Issue
|
|
Pulpfiction
|
22 |
5.9K |
1 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
22
|
5.9K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
530 |
257K |
26 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
530
|
257K
|
26
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
530 |
257K |
8 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
530
|
257K
|
8
|
|
ASX - By Stock
|
PCL |
Re:
General Thoughts
|
|
Pulpfiction
|
5.3K |
2.5M |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
5.3K
|
2.5M
|
1
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
5 |
1.5K |
4 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
5
|
1.5K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Webinar Presentation
|
|
Pulpfiction
|
14 |
4.4K |
3 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
14
|
4.4K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
113 |
46K |
9 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
113
|
46K
|
9
|
|
ASX - By Stock
|
EMD |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
Pulpfiction
|
28 |
6.2K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
28
|
6.2K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Pulpfiction
|
1.0K |
305K |
15 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.0K
|
305K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Pulpfiction
|
1.0K |
305K |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.0K
|
305K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
Pulpfiction
|
112 |
37K |
10 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
112
|
37K
|
10
|
|
ASX - By Stock
|
PCL |
Re:
Ann: PEL 87 Project Update
|
|
Pulpfiction
|
95 |
50K |
9 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
95
|
50K
|
9
|
|
ASX - By Stock
|
PCL |
Re:
Ann: PEL 87 Project Update
|
|
Pulpfiction
|
95 |
50K |
10 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
95
|
50K
|
10
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Completion of Metallurgical Diamond Drilling at Earaheedy
|
|
Pulpfiction
|
4 |
3.0K |
9 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
4
|
3.0K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Resubmission of NDA for Sofdra Completed
|
|
Pulpfiction
|
108 |
28K |
11 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
108
|
28K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL
|
|
Pulpfiction
|
37 |
18K |
8 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
37
|
18K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL
|
|
Pulpfiction
|
37 |
18K |
13 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
37
|
18K
|
13
|
|
ASX - By Stock
|
ILA |
Re:
ILA - Media coverage
|
|
Pulpfiction
|
12 |
2.6K |
4 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
12
|
2.6K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
Pulpfiction
|
81 |
22K |
7 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
81
|
22K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
Pulpfiction
|
81 |
22K |
5 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
81
|
22K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
3.7M |
10 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
10K
|
3.7M
|
10
|
|
ASX - By Stock
|
NC6 |
Re:
3 cents! Options are worthless. Where to now?
|
|
Pulpfiction
|
29 |
7.2K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
29
|
7.2K
|
3
|
|
ASX - By Stock
|
NC6 |
Re:
3 cents! Options are worthless. Where to now?
|
|
Pulpfiction
|
29 |
7.2K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
29
|
7.2K
|
2
|
|